Lipocine (STU:2VT0) Purchase Of Investment : €-21.22 Mil (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Lipocine Purchase Of Investment?

Lipocine's purchase of investment for the three months ended in Dec. 2023 was €-8.59 Mil. It means Lipocine spent €8.59 Mil on purchasing investments. Lipocine's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2023 was €-21.22 Mil.

Compared with last quarter (€-4.46 Mil in Sep. 2023 ), Lipocine spent more money on purchasing investments in Dec. 2023 (€-8.59 Mil).

Lipocine Purchase Of Investment Historical Data

The historical data trend for Lipocine's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipocine Purchase Of Investment Chart

Lipocine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Investment

Get a 7-Day Free Trial

-15.17

-5.19

-42.85

-42.55

-21.00

Lipocine Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Purchase Of Investment	Get a 7-Day Free Trial															-10.86	-6.02	-2.16	-4.46	-8.59

Lipocine Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-21.22 Mil.

Lipocine Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Lipocine's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipocine (STU:2VT0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipocine Inc (STU:2VT0) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

LPCN:USA

Address

675 Arapeen Drive, Suite 202, Salt Lake City, UT, USA, 84108

Website

http://www.lipocine.com

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107.

Lipocine (STU:2VT0) Headlines

No Headlines